Company Overview and News
Integrating Innovation, Art and Commerce, New K11 Atelier office concept redefines work space at game-changing Victoria Dockside site in Kowloon; New mixed-use commercial building makes waves in drawing global finance firms Mizuho Bank and Taipei Fubon Bank across the Harbour to the iconic Tsim Sha Tsui harbourfront
35,245 square metre land parcel on Yongning Street in Zengcheng District on the eastern outskirts of the Guangdong provincial capital
Game-changing, mixed-use harbourfront development spearheaded by New World Development aims to set new standards in art, design and leisure
Hong Kong property conglomerate New World Development has committed to invest 14.52 billion yuan (HK$16.34 billion) under joint venture vehicles that will develop four high-quality parcels of land at Prince Bay in Shenzhen.
HONGKONG, 16. November 2016 /PRNewswire/ -- Rosewood Hotels & Resorts® wird 2018 das erste Objekt der Ultra-Luxusmarke in Hongkong an einem erstklassigen Standort mit Blick auf den Victoria Harbour am ehemaligen New World Centre in der Salisbury Road in Tsim Sha Tsui eröffnen. Rosewood Hongkong wird 27 Stockwerke des Mehrzwecktowers, der im Besitz der New World Development Company Limited ist, belegen, dessen markante Form und leuchtende Spitze prädestiniert sind, zu einem sofort wieder erkennbaren Wahrzeichen der berühmten Skyline zu werden.
HONG KONG, 16 novembre 2016 /PRNewswire/ -- Rosewood Hotels & Resorts® ouvrira sa première propriété haut de gamme à Hong Kong à un emplacement privilégié, en front de mer du Victoria Harbour, à l'ancien New World Centre sur Salisbury Road à Tsim Sha Tsui. Rosewood Hong Kong occupera 27 étages de la tour à usage polyvalent et détenue par New World Development Company Limited dont la forme distincte avec sa couronne scintillante est destinée à devenir un emblème instantanément reconnaissable dans la silhouette de la ville.
HONG KONG, Nov. 16, 2016 /PRNewswire/ -- Rosewood Hotels & Resorts® will open the ultra-luxury brand's first Hong Kong property in 2018 in a prime Victoria Harbour waterfront location at the former New World Centre on Salisbury Road in Tsim Sha Tsui. Rosewood Hong Kong will occupy 27 floors of a multi-use tower owned by New World Development Company Limited, whose distinct form and glowing crown is destined to become an instantly recognizable landmark on the famous skyline.
The developer’s full-year underlying profit gained 1.77 per cent to HK$6.89 billion, boosted by sale of mainland assets
One day after Hong Kong’s richest man warned that Hong Kong has been experiencing some of its toughest economic challenges in two decades, one other property heavyweight weighed in with a note of pessimism.
Company reports exchange loss of HK$1.25 billion due to devaluation of yuan
Merger and acquisition (M&A) activities in Chengdu’s property market reached a fever pitch last year and is expected to continue as deals are expected to come thick and fast in a depressed market, say industry experts.
Devaluation of the yuan, economic slowdown, high inventories and surging land costs prompt new investment strategy
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...
2018-05-19 - Asif
Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...
2018-05-17 - Asif
Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...